The study, by the Florida Society of Interventional Pain Physicians, evaluated mild patients six weeks following the procedure using the Zurich Claudication Questionnaire. Patients rated their overall satisfaction at a 2.02 on a scale from 1 to 4, with 1 being the highest score.
Vertos mild is FDA-approved for treating central canal stenosis of the lumbar spine.
Read the Vertos release on the MiDAS I clinical trial (pdf).
